Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-12-08 Purchase | 2023-12-11 4:30 pm | Generation Bio Co. | GBIO | Appelhans Dannielle Director | 8,000 | $1.7924 | $14,339 | 20,000 (Indirect Direct) | View |
| 2023-12-04 Purchase | 2023-12-06 4:30 pm | Generation Bio Co. | GBIO | Appelhans Dannielle Director | 12,000 | $1.5 | $18,000 | 12,000 (Direct) | View |
| 2023-02-24 Sale | 2023-02-27 6:08 pm | Rubius Therapeutics Inc. | RUBY | Appelhans Dannielle CEO and President | 10,385 | $0.1274 | $1,323 | 0 (Direct) | View |
| 2023-02-01 Sale | 2023-02-01 9:40 pm | Rubius Therapeutics Inc. | RUBY | Appelhans Dannielle CEO and President | 3,878 | $0.25 | $970 | 32,885 (Direct) | View |
| 2022-08-10 Sale | 2022-08-12 3:06 pm | Rubius Therapeutics Inc. | RUBY | Appelhans Dannielle Chief Operating Officer | 5,737 | $0.8 | $4,590 | 44,263 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-06 Option Award | 2024-06-10 4:05 pm | N/A 2034-06-05 | Generation Bio Co. | GBIO | Appelhans Dannielle Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 4:15 pm | N/A 2033-06-07 | Generation Bio Co. | GBIO | Appelhans Dannielle Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-01-31 Exercise | 2023-02-01 9:40 pm | N/A N/A | Rubius Therapeutics Inc. | RUBY | Appelhans Dannielle CEO and President | 7,500 | $0 | 32,885 (Direct) | View |
| 2022-08-09 Exercise | 2022-08-12 3:06 pm | N/A N/A | Rubius Therapeutics Inc. | RUBY | Appelhans Dannielle Chief Operating Officer | 12,500 | $0 | 44,263 (Direct) | View |
| 2022-07-15 Option Award | 2022-07-19 4:07 pm | N/A 2032-07-14 | Generation Bio Co. | GBIO | Appelhans Dannielle Director | 38,400 | $0 | 38,400 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-01 9:19 pm | N/A 2032-01-30 | Rubius Therapeutics Inc. | RUBY | Appelhans Dannielle Chief Operating Officer | 155,000 | $0 | 155,000 (Direct) | View |
| 2021-08-31 Option Award | 2021-09-01 8:12 pm | N/A 2031-08-30 | Rubius Therapeutics Inc. | RUBY | Appelhans Dannielle Chief Operating Officer | 200,000 | $0 | 200,000 (Direct) | View |